https://touchoncology.com/insight/breast-cancer-and-covid-19-answers-to-frequently-asked-questions/ 2022-02-01T14:46:59+00:00 https://touchoncology.com/insight/asco20-virtual-highlights-key-trials-and-new-data-in-prostate-cancer/ 2022-02-01T14:46:13+00:00 https://touchoncology.com/insight/2019-highlights-a-look-back-at-siop-europes-year/ 2022-01-31T12:37:07+00:00 http://touchoncology.com/wp-content/uploads/sites/2/2019/12/SIOP.jpg https://touchoncology.com/insight/letter-from-the-president-of-the-european-society-for-paediatric-oncology-siope-covid-19-resources-and-guidance/ 2022-01-31T11:55:20+00:00 https://touchoncology.com/insight/childhood-cancer-awareness-month-shine-gold-on-our-young-heroes-survivors/ 2021-06-25T16:11:15+00:00 https://touchoncology.com/wp-content/uploads/sites/2/2018/12/SIOPE-ribbon-logo.png http://touchoncology.com/wp-content/uploads/sites/2/2020/09/CCI-Logo-Europe_170x105.png http://touchoncology.com/wp-content/uploads/sites/2/2020/09/PanCare-logo_170x105.png https://touchoncology.com/insight/welcoming-the-2020-ema-ec-progress-report-on-the-action-plan-on-paediatrics/ 2020-12-18T11:34:00+00:00 http://touchoncology.com/wp-content/uploads/sites/2/2020/12/Accelerate2020-Banner-1170x4022-platform2.jpg https://touchoncology.com/insight/liquid-biopsies-to-predict-therapeutic-response-the-solar-1-study/ 2020-08-11T10:27:46+00:00 https://touchoncology.com/insight/adjuvant-ado-trastuzumab-emtansine-reduces-the-risk-of-recurrence-compared-to-trastuzumab-in-early-stage-her2-positive-breast-cancer/ 2020-08-11T10:27:27+00:00 https://touchoncology.com/insight/the-prognostic-significance-of-tp-53-clone-size-in-relapsed-refractory-cll-patients-in-the-murano-study/ 2020-08-11T10:26:23+00:00 https://touchoncology.com/insight/efficacy-and-safety-of-cd22-directed-car-t-cell-therapy-in-children-with-refractory-or-relapsed-b-acute-lymphoblastic-leukaemia/ 2020-08-11T10:26:05+00:00 https://touchoncology.com/insight/is-relevance-relevant-lenalomide-plus-rituximab-is-not-more-effective-than-rituximab-plus-chemotherapy-followed-by-rituximab-in-first-line-follicular-lymphoma/ 2020-08-11T10:25:50+00:00 https://touchoncology.com/insight/short-acting-calcium-channel-blockers-may-double-the-risk-of-pancreatic-cancer-in-postmenopausal-women/ 2020-08-11T10:23:26+00:00 https://touchoncology.com/insight/pembrolizumab-latest-data-on-its-use-as-monotherapy-and-in-combination-with-chemotherapy-in-non-small-cell-lung-cancer/ 2020-08-11T10:23:09+00:00 https://touchoncology.com/insight/durvalumab-first-immunotherapy-to-be-approved-for-stage-iii-non-small-cell-lung-cancer/ 2020-08-11T10:20:28+00:00 http://touchoncology.com/wp-content/uploads/sites/2/2018/02/www.touchrespiratory.com_sites_www.touchrespiratory.co_.uk_files_ongoing-clinical-trials.png https://touchoncology.com/insight/the-quest-for-a-liquid-assay-for-cancer-detection-the-circulating-cell-free-genome-atlas-ccga-study/ 2020-08-11T10:19:51+00:00 https://touchoncology.com/insight/clinical-development-of-taselisib-in-advanced-breast-cancer-scrapped-after-modest-efficacy-data-presented-at-asco/ 2020-08-11T10:17:48+00:00 https://touchoncology.com/insight/adjuvant-use-of-immune-checkpoint-inhibitors-after-resection-of-advanced-melanoma/ 2020-08-11T10:17:33+00:00 https://touchoncology.com/insight/enzalutamide-treatment-in-men-with-nonmetastatic-prostate-cancer-results-of-the-prosper-study/ 2020-08-11T10:17:07+00:00 https://touchoncology.com/insight/efficacy-and-safety-of-sorafenib-in-patients-with-metastatic-renal-cell-carcinoma-after-a-radical-resection-of-the-metastases-the-resort-trial/ 2020-08-11T10:16:52+00:00 https://touchoncology.com/insight/pembrolizumab-plus-axitinib-improves-survival-as-first-line-treatment-in-patients-with-renal-cell-carcinoma/ 2020-08-11T10:16:38+00:00 https://touchoncology.com/insight/car-t-cell-therapy-for-relapsed-or-refractory-large-b-cell-lymphoma-latest-data-from-the-zuma-1-study/ 2020-08-11T10:12:34+00:00 https://touchoncology.com/insight/acalabrutinib-in-mantle-cell-lymphoma-new-long-term-data-announced/ 2020-08-11T10:12:14+00:00 https://touchoncology.com/insight/the-believe-trial-luspatercept-in-adult-beta-thalassemia-patients-who-require-regular-red-blood-cell-transfusions/ 2020-08-11T10:11:58+00:00 https://touchoncology.com/insight/rivaroxaban-reduces-the-risk-of-venous-thromboembolism-in-cancer-patients/ 2020-08-11T10:11:41+00:00 https://touchoncology.com/insight/cytotoxic-t-lymphocyte-therapy-in-the-treatment-of-epstein-barr-virus-associated-post-transplant-lymphoproliferative-disorder/ 2020-08-11T10:11:22+00:00 https://touchoncology.com/insight/tisagenlecleucel-in-paediatric-and-young-adult-patients-with-relapsed-and-refractory-acute-lymphoblastic-leukaemia-new-data-from-the-eliana-study/ 2020-08-11T10:10:58+00:00 https://touchoncology.com/insight/esmo-2018-immunotherapy-may-become-new-first-line-treatment-in-some-metastatic-colorectal-cancers/ 2020-08-11T10:07:10+00:00 https://touchoncology.com/insight/clovis-oncology-presents-first-data-from-the-triton-prostate-program-evaluating-rucaparib-in-metastatic-prostate-cancer-at-esmo-2018/ 2020-08-11T10:06:15+00:00 https://touchoncology.com/insight/results-from-solo-1-presented-at-esmo-2018-impressive-findings-for-olaparip-maintenance-therapy-in-patients-with-newly-diagnosed-advanced-brca-mutated-ovarian-cancer/ 2020-08-11T10:05:53+00:00 https://touchoncology.com/insight/methods-of-counteracting-the-spread-of-covid-19-a-case-study-of-the-temporary-medical-camp-in-brovary-ukraine/ 2020-08-07T12:41:02+00:00 https://touchoncology.com/insight/the-covid-19-pandemic-and-the-long-term-effects-on-uk-general-practice/ 2020-06-22T20:24:22+00:00 https://touchoncology.com/insight/treatments-for-covid-19-an-update-on-current-clinical-trials/ 2020-04-30T07:38:39+00:00 https://touchoncology.com/insight/the-impact-of-covid-19-on-the-care-of-patients-with-heamatologic-malignancies/ 2020-04-09T16:05:34+00:00 https://touchoncology.com/insight/news-statement-on-covid-19-from-the-european-cancer-organisations-board-of-directors/ 2020-03-30T12:00:36+00:00 http://touchoncology.com/wp-content/uploads/sites/2/2020/03/ECCO.jpg https://touchoncology.com/insight/covid-19-the-changing-landscape-in-oncology/ 2020-03-30T12:00:28+00:00 https://touchoncology.com/insight/be-fast-have-no-regrets-protecting-oncology-patients-in-the-coronavirus-pandemic/ 2020-03-30T11:59:48+00:00 https://touchoncology.com/insight/feedback-fromnews-feedback-from-the-european-cancer-organisation-ecco/ 2020-03-30T11:15:18+00:00 http://touchoncology.com/wp-content/uploads/sites/2/2020/03/ECCO.jpg https://touchoncology.com/insight/teenagers-with-cancer-set-to-benefit-from-international-initiative-aimed-at-lowering-the-age-of-participation-to-potentially-life-saving-treatments/ 2020-03-03T11:22:09+00:00 http://touchoncology.com/wp-content/uploads/sites/2/2020/02/Picture1.jpg https://touchoncology.com/insight/breaking-through-limits-together-a-look-at-the-formation-of-the-lung-ambition-alliance-2/ 2019-09-09T07:45:04+00:00